iShares Biotechnology ETF (IBB) Holdings $121.25 -0.17 (-0.14%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$120.73 -0.52 (-0.43%) As of 05/23/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock Top 100 IBB HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$436.00+0.5%8.42%1,001,9712AMGNAmgen$271.66-0.1%8.20%1,560,5543GILDGilead Sciences$107.37+0.6%8.16%4,205,6094REGNRegeneron Pharmaceuticals$588.34-1.4%7.46%659,2335ALNYAlnylam Pharmaceuticals$289.96+0.3%4.24%774,2416IQVIQVIA$136.96-0.8%2.96%1,090,4267ARGXargenx$587.61+1.1%2.86%263,5278MTDMettler-Toledo International$1,115.43-1.8%2.85%128,7739WATWaters$346.59-0.5%2.52%370,67910NTRANatera$153.32+0.6%2.31%798,958 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11BIIBBiogen$125.81-0.4%2.18%910,69512BNTXBioNTech$98.68-0.4%1.82%1,020,59413UTHRUnited Therapeutics$307.65-0.3%1.62%275,57114ILMNIllumina$80.37-0.2%1.54%985,78615EXELExelixis$42.39-1.1%1.52%1,703,71616ONCBeigene$241.43+1.1%1.50%343,70917INCYIncyte$64.25-0.4%1.45%1,192,66718INSMInsmed$67.53+2.1%1.44%1,105,53619NBIXNeurocrine Biosciences$120.18+0.9%1.41%605,60520BMRNBioMarin Pharmaceutical$57.55-0.8%1.33%1,177,87221GMABGenmab A/S$20.81-1.0%1.10%2,886,61522MRNAModerna$26.26-1.7%0.98%2,137,32323TECHBio-Techne$46.78-1.1%0.91%977,65924MEDPMedpace$294.89+0.6%0.90%156,29525CRLCharles River Laboratories International$136.76+0.9%0.85%316,32426ASNDAscendis Pharma A/S$162.00+1.2%0.80%262,78427RGENRepligen$118.15-1.9%0.79%330,66628RVMDRevolution Medicines$39.77+2.5%0.77%1,010,48329BPMCBlueprint Medicines$101.50+1.2%0.76%392,37030HALOHalozyme Therapeutics$54.54+1.5%0.72%761,66531MDGLMadrigal Pharmaceuticals$267.56-2.1%0.66%116,41632IONSIonis Pharmaceuticals$32.98-0.8%0.62%967,61233BBIOBridgeBio Pharma$33.34+1.1%0.61%933,99034ALKSAlkermes$29.35-2.3%0.60%991,54935TEMTempus AI$62.56+5.6%0.59%487,31136ROIVRoivant Sciences$10.87-0.6%0.58%2,766,22737ADMAADMA Biologics$20.42+1.3%0.53%1,424,49138AXSMAxsome Therapeutics$105.07+0.7%0.52%250,56139PCVXVaxcyte$32.54-4.2%0.47%782,48040BRKRBruker$35.50-2.3%0.46%644,621Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos41LEGNLegend Biotech$28.91-0.5%0.43%793,43142VRNAVerona Pharma$75.06+3.3%0.43%317,82643CYTKCytokinetics$30.54+0.2%0.42%720,76544PTCTPTC Therapeutics$45.93+0.9%0.42%481,05945RYTMRhythm Pharmaceuticals$62.36+0.6%0.41%351,25246RNAAvidity Biosciences$30.58-0.7%0.39%693,94247KRYSKrystal Biotech$125.05-0.2%0.39%153,73548SWTXSpringWorks Therapeutics$46.48+0.5%0.39%438,54349NUVLNuvalent$73.49+0.4%0.38%277,03950SRPTSarepta Therapeutics$37.90-2.3%0.38%562,23551CRSPCRISPR Therapeutics$36.86-1.8%0.36%514,38952RAREUltragenyx Pharmaceutical$35.66+0.4%0.36%540,30253ACADACADIA Pharmaceuticals$21.98+2.0%0.35%1,033,95154CRNXCrinetics Pharmaceuticals$29.76-1.2%0.33%541,32855AKROAkero Therapeutics$46.36-5.3%0.32%416,16056SMMTSummit Therapeutics$25.85+0.3%0.32%718,06157PTGXProtagonist Therapeutics$45.66-0.5%0.31%361,08758MRUSMerus$55.14+32.5%0.30%382,75459ACLXArcellx$63.92-2.0%0.28%251,83060SRRKScholar Rock$30.00-1.5%0.27%456,02161XENEXenon Pharmaceuticals$29.75-2.4%0.27%463,60262VCYTVeracyte$27.16-0.9%0.26%478,35463ZLABZai Lab$31.32-3.6%0.26%473,02964VCELVericel$40.92-1.1%0.25%308,85365BCRXBioCryst Pharmaceuticals$10.59+1.9%0.24%1,231,62066DNLIDenali Therapeutics$13.42-1.8%0.22%785,41467TVTXTravere Therapeutics$15.84+0.9%0.22%545,91368FOLDAmicus Therapeutics$6.22-0.6%0.21%1,852,84169MIRMMirum Pharmaceuticals$44.00-0.1%0.21%243,22470NVCRNovoCure$18.54+2.4%0.21%617,52071TWSTTwist Bioscience$28.26+0.4%0.21%352,11372APLSApellis Pharmaceuticals$17.44-1.9%0.20%646,90573KYMRKymera Therapeutics$29.49-2.3%0.20%337,72574AGIOAgios Pharmaceuticals$29.80+0.7%0.19%344,93675ARWRArrowhead Pharmaceuticals$15.13-1.7%0.19%655,68376APGEApogee Therapeutics$39.48-2.2%0.18%225,74977BEAMBeam Therapeutics$16.83-2.4%0.18%550,03978GRFSGrifols$8.11-0.2%0.18%1,188,82579ARQTArcutis Biotherapeutics$13.98+2.3%0.17%652,47580BHVNBiohaven$15.67+1.5%0.17%552,01281IDYAIDEAYA Biosciences$18.82+0.7%0.17%504,52482TARSTarsus Pharmaceuticals$42.98+0.0%0.17%206,78683MNKDMannKind$4.12-2.4%0.16%1,841,59584ADPTAdaptive Biotechnologies$8.93+1.0%0.15%891,75285RXRXRecursion Pharmaceuticals$4.08-1.4%0.15%1,855,60686ALVOAlvotech$10.28+3.4%0.14%681,86087CGONCG Oncology$25.44-1.2%0.14%288,19888DVAXDynavax Technologies$9.80-0.2%0.14%740,81489JANXJanux Therapeutics$25.22+0.0%0.14%300,46690STVNStevanato Group€22.24-1.6%0.14%309,094Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos91ETNB89bio$9.49-1.7%0.13%866,83192EWTXEdgewise Therapeutics$14.21+1.4%0.13%462,62993GRALGrail$40.18+3.6%0.13%175,20794MESOMesoblast$10.85+0.2%0.13%553,46995NAMSNewAmsterdam Pharma$17.61-3.7%0.13%353,98796VERAVera Therapeutics$19.64+0.1%0.13%303,58197AUPHAurinia Pharmaceuticals$8.08-2.3%0.12%771,75298IRONDisc Medicine$47.37-1.4%0.12%132,57799DYNDyne Therapeutics$11.69-1.8%0.12%525,012100IMVTImmunovant$14.46-0.7%0.12%433,293 Geographic ExposureUnited States96.4%Ireland0.6%Bermuda0.6%Canada0.5%Netherlands0.5%Switzerland0.4%Jersey0.2%Virgin Islands, British0.2%Italy0.1%Luxembourg0.1%Singapore0.1%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care99.1%Consumer Discretionary0.3%Biotechnology0.1%Industrials0.1%Energy0.1%Industry ExposureBiotechnology80.8%Health Care Equipment & Supplies9.1%Health Care Providers & Services6.0%Pharmaceuticals1.6%Life Sciences Tools & Services1.0%Diversified Consumer Services0.9%Distributors0.2%Commercial Services & Supplies0.1%Renewable Energy0.1%Chemicals0.1%SubIndustry ExposureBiotechnology76.8%Life Sciences Tools & Services10.6%Health Care Services6.0%Pharmaceuticals2.4%Health Care Equipment0.4%Renewable Energy Equipment0.1%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies PPH Holdings BBH Holdings PSCH Holdings PTH Holdings LFSC Holdings BIB Holdings HEAL Holdings IBBQ Holdings FTXH Holdings MEDX Holdings This page (NASDAQ:IBB) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBB Stock Free IBB Stock Alerts